科研成果
轉錄因子Sox2通過Wnt/β-catenin信號通路對小細胞肺癌化療耐藥的調控機制研究 2015 2015A030310528 廣東省自然科學基金博士啟動基金 (第二)
學術成就
How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: an international multidisciplinary team.2018.J Thorac Dis.Jun;10(6):3883-3890.
Association between epidermal growth factor receptor gene copy number and ERCC1, BRCA1 protein expression in Chinese patients with non-small cell lung cancer.
2014 Med Oncol. Mar;31(3):803.
High expression levels of class III β-tubulin in resected non-small cell lung cancer patients are predictive of improved patient survival after vinorelbine-based adjuvant chemotherapy. 2013 Oncol Lett. Jul;6(1):220-226.
The development of targeted therapy in small cell lung cancer. 2013 J Thorac Dis. Aug;5(4):538-48.
社會任職
廣東省精準醫學套用學會肺癌分會常務委員
廣州抗癌協會腫瘤微環境專業委員會委員
擅長領域
主要從事胸部腫瘤的防治,擅長晚期肺癌的化療、靶向治療、免疫治療、生存預後等方面的研究,對小細胞肺癌的治療也頗有心得,同時對腫瘤患者的臨床營養評估與干預有獨到的體會。